Annette North - EVP & General Counsel at Turning Point Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP & General Counsel
Stock Symbol
TPTX
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Annette North since 7/4/2023

Holdings reported by Annette North for Turning Point Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 27,979 $2.13 M $76.00 Feb 9, 2022 Direct
Stock Option (right to buy) 58,600 Feb 9, 2022 Direct Common Stock

Transactions reported by Annette North for Turning Point Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership